Patients prefer specific info from docs for prostate cancer

March 11, 2014
Patients prefer specific info from docs for prostate cancer

(HealthDay)—Although patients with prostate cancer endorse multiple sources of information, they report greatest satisfaction with information from the treating physician about patient outcomes, according to research to be published in the May issue of The Journal of Urology.

Scott M. Gilbert, M.D., of the University of Michigan in Ann Arbor, and colleagues conducted a prospective, multicenter study of 1,204 men with newly diagnosed prostate cancer. Patients completed questionnaires regarding their use of information and satisfaction with information related to selection of treatment.

The researchers found that prostate cancer patients reported description of treatment by the treating physician (33.1 percent), Internet sites (18.9 percent), and books (18.1 percent) as the most helpful sources of information. Variables that were independently associated with patient satisfaction with the information provided were patient age (P = 0.005) and information from the physician about outcomes in their patients (P = 0.01).

"For patients, the impact of treatment on health-related quality of life is an important consideration. Reliable pretreatment information may allow patients to set expectations regarding treatment outcomes and make informed decisions in selecting therapy," a coauthor said in a statement. "Our results indicate that outcome information specific to the treating physician is associated with greater patient satisfaction following treatment, and that this type of information may assist patients in the ."

Several authors disclosed financial ties to pharmaceutical and biomedical companies.

Explore further: Reliable pretreatment information assists prostate cancer patients in decision-making

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Reliable pretreatment information assists prostate cancer patients in decision-making

March 4, 2014
Men who have been diagnosed with prostate cancer need to assimilate information rapidly in order to weigh the treatment options and make informed decisions. Although patients consult a variety of information sources, outcome ...

Complementary medicine not tied to prostate cancer outcome

May 4, 2012
(HealthDay) -- Although widely used, complementary and alternative medicine (CAM) does not impact patient satisfaction with treatment or patient-reported outcomes after treatment for localized prostate cancer, according to ...

Surgery better for most men with localised prostate cancer

February 27, 2014
Surgery offers better survival rates for most men with localised prostate cancer than radiotherapy, according to one of the largest studies of its type.

New prostate cancer treatment convenient, less expensive, but may be riskier

March 10, 2014
A faster and less expensive form of radiotherapy for treating prostate cancer may come at a price, according to a new study by Yale School of Medicine researchers—a higher rate of urinary complications.

Positive outcomes with improved hemorrhoidectomy information

January 3, 2014
(HealthDay)—For patients undergoing day-case hemorrhoidectomy, improved quality of patient information is associated with positive outcomes, according to a study published in the November/December issue of the Journal of ...

Added prostate CA criteria may help ID surveillance candidates

January 24, 2014
(HealthDay)—Additional predictors, such as prostate-specific antigen (PSA) density and extent of cancer on biopsy, help guide selection of prostate cancer patients for active surveillance programs, according to research ...

Recommended for you

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.